Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.38 |
| ▸ | CD81 | P60033 | 1/20 | 0.36 |
| ▸ | FNTA | P49354 | 1/20 | 0.33 |
| ▸ | FNTB | P49356 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4332042 | 1.00 | EP300 (0.44) | EP300TBXAS1FOLH1CD81FNTA | |
| SCHEMBL4335020 | 1.00 | EP300 (0.44) | EP300TBXAS1FOLH1CD81FNTA | |
| SCHEMBL4351549 | 1.00 | EP300 (0.44) | EP300TBXAS1FOLH1CD81FNTA | |
| SCHEMBL8332563 | 1.00 | EP300 (0.44) | EP300TBXAS1FOLH1CD81FNTA | |
| SCHEMBL8332024 | 1.00 | EP300 (0.44) | EP300TBXAS1FOLH1CD81FNTA | |
| SCHEMBL723347 | 0.98 | EP300 (0.41) | EP300TBXAS1FOLH1CD81FNTA | |
| SCHEMBL720675 | 0.91 | CD81 (0.38) | EP300TBXAS1FOLH1CD81FNTA | |
| SCHEMBL4347400 | 0.91 | CD81 (0.38) | EP300TBXAS1FOLH1CD81FNTA | |
| SCHEMBL19510524 | 0.89 | EP300 (0.52) | EP300TBXAS1CD81FNTAFNTB | |
| SCHEMBL7857040 | 0.89 | EP300 (0.52) | EP300TBXAS1CD81FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3733114-B1 | DENTAL MILL BLANK AND METHOD FOR PRODUCING SAME | KURARAY NORITAKE DENTAL INC (JP) | 2024-04-17 | — | — | EP | disclosed |
| US-11707346-B2 | Dental mill blank and method for producing same | KURARAY NORITAKE DENTAL INC. (JP) | 2023-07-25 | — | — | US | disclosed |
| US-20200360120-A1 | DENTAL MILL BLANK AND METHOD FOR PRODUCING SAME | KURARAY NORITAKE DENTAL INC. (JP) | 2020-11-19 | — | — | US | disclosed |
| EP-3733114-A1 | DENTAL MILL BLANK AND METHOD FOR PRODUCING SAME | Kuraray Noritake Dental Inc. (JP) | 2020-11-04 | — | — | EP | disclosed |
| WO-2020138472-A1 | DENTAL MILL BLANK HAVING OPTIMIZED COLOR TONE | クラレノリタケデンタル株式会社 | 2020-07-02 | — | — | WO | disclosed |
| EP-3556814-A1 | METHOD FOR PRODUCING SURFACE-TREATED COLORED INORGANIC PARTICLES | Kuraray Noritake Dental Inc. (JP) | 2019-10-23 | — | — | EP | disclosed |
| US-20190315970-A1 | METHOD FOR PRODUCING SURFACE-TREATED COLORED INORGANIC PARTICLES | KURARAY NORITAKE DENTAL INC. (JP) | 2019-10-17 | — | — | US | disclosed |
| US-9089482-B2 | Dental mill blank | KURARAY NORITAKE DENTAL INC. (JP) | 2015-07-28 | — | — | US | disclosed |
| US-20130172441-A1 | DENTAL MILL BLANK | KURARAY NORITAKE DENTAL INC. (JP) | 2013-07-04 | — | — | US | disclosed |
| US-8436078-B2 | Dental composition and composite resin | KURARAY NORITAKE DENTAL INC. (JP) | 2013-05-07 | — | — | US | disclosed |
| US-20110046260-A1 | DENTAL COMPOSITION AND COMPOSITE RESIN | KURARAY MEDICAL INC. (JP) | 2011-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046260-A1 | DENTAL COMPOSITION AND COMPOSITE RESIN | CAD, ITGB5, ITGA5 | EP300 3357/4885TBXAS1 4622/4885FOLH1 4759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.